| 2016 | Phase I Study of CD8 Memory T-Cell Donor Lymphocyte Infusion for Relapse of Hematologic Malignancies Following Matched Related Donor Allogeneic Hematopoietic Cell Transplantation | Muffly, L. S.; Sheehan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Rezvani, A. R.; Miklos, D.; Arai, S.; Shizuru, J.; Johnston, L.; Meyer, E.; Wen-Kai Weng ; Laport, G. G.; Negrin, R. S.; Strober, S.; Lowsky, R. | Blood | | | |
| 2018 | Phase I/II Trial for Patients with Advanced Hematologic Malignancies Undergoing Myeloablative Allogeneic HCT with a T Cell Depleted Graft with Infusion of Conventional T Cells and Regulatory T Cells | Meyer, E.; Laport, G. G.; Tantsura, I.; Tang, S. W.; Sahaf, B.; Rangarajan, K.; Armstrong, R.; Tate, K.; Tudisco, C.; Sheehan, K.; Arai, S.; Johnston, L.; Muffly, L.; Lowsky, R.; Rezvani, A.; Wen-Kai Weng ; Miklos, D.; Negrin, R. S. | Biology of Blood and Marrow Transplantation | | | |
